Co-benefits from sustainable dietary shifts for population and environmental health: an assessment from a large European cohort study.


Journal

The Lancet. Planetary health
ISSN: 2542-5196
Titre abrégé: Lancet Planet Health
Pays: Netherlands
ID NLM: 101704339

Informations de publication

Date de publication:
11 2021
Historique:
received: 02 06 2020
revised: 08 07 2021
accepted: 20 08 2021
pubmed: 25 10 2021
medline: 22 3 2022
entrez: 24 10 2021
Statut: ppublish

Résumé

Unhealthy diets, the rise of non-communicable diseases, and the declining health of the planet are highly intertwined, where food production and consumption are major drivers of increases in greenhouse gas emissions, substantial land use, and adverse health such as cancer and mortality. To assess the potential co-benefits from shifting to more sustainable diets, we aimed to investigate the associations of dietary greenhouse gas emissions and land use with all-cause and cause-specific mortality and cancer incidence rates. Using data from 443 991 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, a multicentre prospective cohort, we estimated associations between dietary contributions to greenhouse gas emissions and land use and all-cause and cause-specific mortality and incident cancers using Cox proportional hazards regression models. The main exposures were modelled as quartiles. Co-benefits, encompassing the potential effects of alternative diets on all-cause mortality and cancer and potential reductions in greenhouse gas emissions and land use, were estimated with counterfactual attributable fraction intervention models, simulating potential effects of dietary shifts based on the EAT-Lancet reference diet. In the pooled analysis, there was an association between levels of dietary greenhouse gas emissions and all-cause mortality (adjusted hazard ratio [HR] 1·13 [95% CI 1·10-1·16]) and between land use and all-cause mortality (1·18 [1·15-1·21]) when comparing the fourth quartile to the first quartile. Similar associations were observed for cause-specific mortality. Associations were also observed between all-cause cancer incidence rates and greenhouse gas emissions, when comparing the fourth quartile to the first quartile (adjusted HR 1·11 [95% CI 1·09-1·14]) and between all-cause cancer incidence rates and land use (1·13 [1·10-1·15]); however, estimates differed by cancer type. Through counterfactual attributable fraction modelling of shifts in levels of adherence to the EAT-Lancet diet, we estimated that up to 19-63% of deaths and up to 10-39% of cancers could be prevented, in a 20-year risk period, by different levels of adherence to the EAT-Lancet reference diet. Additionally, switching from lower adherence to the EAT-Lancet reference diet to higher adherence could potentially reduce food-associated greenhouse gas emissions up to 50% and land use up to 62%. Our results indicate that shifts towards universally sustainable diets could lead to co-benefits, such as minimising diet-related greenhouse gas emissions and land use, reducing the environmental footprint, aiding in climate change mitigation, and improving population health. European Commission (DG-SANCO), the International Agency for Research on Cancer (IARC), MRC Early Career Fellowship (MR/M501669/1).

Sections du résumé

BACKGROUND
Unhealthy diets, the rise of non-communicable diseases, and the declining health of the planet are highly intertwined, where food production and consumption are major drivers of increases in greenhouse gas emissions, substantial land use, and adverse health such as cancer and mortality. To assess the potential co-benefits from shifting to more sustainable diets, we aimed to investigate the associations of dietary greenhouse gas emissions and land use with all-cause and cause-specific mortality and cancer incidence rates.
METHODS
Using data from 443 991 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, a multicentre prospective cohort, we estimated associations between dietary contributions to greenhouse gas emissions and land use and all-cause and cause-specific mortality and incident cancers using Cox proportional hazards regression models. The main exposures were modelled as quartiles. Co-benefits, encompassing the potential effects of alternative diets on all-cause mortality and cancer and potential reductions in greenhouse gas emissions and land use, were estimated with counterfactual attributable fraction intervention models, simulating potential effects of dietary shifts based on the EAT-Lancet reference diet.
FINDINGS
In the pooled analysis, there was an association between levels of dietary greenhouse gas emissions and all-cause mortality (adjusted hazard ratio [HR] 1·13 [95% CI 1·10-1·16]) and between land use and all-cause mortality (1·18 [1·15-1·21]) when comparing the fourth quartile to the first quartile. Similar associations were observed for cause-specific mortality. Associations were also observed between all-cause cancer incidence rates and greenhouse gas emissions, when comparing the fourth quartile to the first quartile (adjusted HR 1·11 [95% CI 1·09-1·14]) and between all-cause cancer incidence rates and land use (1·13 [1·10-1·15]); however, estimates differed by cancer type. Through counterfactual attributable fraction modelling of shifts in levels of adherence to the EAT-Lancet diet, we estimated that up to 19-63% of deaths and up to 10-39% of cancers could be prevented, in a 20-year risk period, by different levels of adherence to the EAT-Lancet reference diet. Additionally, switching from lower adherence to the EAT-Lancet reference diet to higher adherence could potentially reduce food-associated greenhouse gas emissions up to 50% and land use up to 62%.
INTERPRETATION
Our results indicate that shifts towards universally sustainable diets could lead to co-benefits, such as minimising diet-related greenhouse gas emissions and land use, reducing the environmental footprint, aiding in climate change mitigation, and improving population health.
FUNDING
European Commission (DG-SANCO), the International Agency for Research on Cancer (IARC), MRC Early Career Fellowship (MR/M501669/1).

Identifiants

pubmed: 34688354
pii: S2542-5196(21)00250-3
doi: 10.1016/S2542-5196(21)00250-3
pmc: PMC8581185
pii:
doi:

Substances chimiques

Greenhouse Gases 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e786-e796

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 International Agency for Research on Cancer; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that IARC endorses any specific organisation, products or services. The use of the IARC logo is not permitted. This notice should be preserved along with the article's original URL.

Déclaration de conflit d'intérêts

Declaration of interests MRB presented at two conferences, which may be a conflict of interest: the MAYOLY-SPINDLER Symposium on pancreatology in practice at the Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive e-conference in 2020 (Why do I see more and more pancreatic cancers?) and the GILEAD e-conference on weight gain and HIV infection in 2020. All other authors declare no competing interests.

Références

Lancet Diabetes Endocrinol. 2019 Mar;7(3):231-240
pubmed: 30704950
Public Health Nutr. 2017 Mar;20(4):739-757
pubmed: 27819199
Am J Epidemiol. 2014 Feb 1;179(3):282-9
pubmed: 24148709
Lancet. 2019 Jul 20;394(10194):213-214
pubmed: 31235280
Am J Clin Nutr. 2011 Oct;94(4):1088-96
pubmed: 21831992
PLoS One. 2016 Nov 3;11(11):e0165797
pubmed: 27812156
Meat Sci. 2017 Oct;132:189-195
pubmed: 28460836
J Nutr. 2020 May 1;150(5):985-988
pubmed: 32061173
Int J Environ Res Public Health. 2017 Apr 27;14(5):
pubmed: 28448460
BMJ. 2019 Jan 28;364:l296
pubmed: 30692128
Nature. 2014 Nov 27;515(7528):518-22
pubmed: 25383533
Environ Sci Technol. 2019 Jul 2;53(13):7694-7703
pubmed: 31145597
Am J Epidemiol. 2009 Jul 15;170(2):244-56
pubmed: 19494242
Ann Oncol. 2017 Aug 1;28(8):1788-1802
pubmed: 28407090
Data Brief. 2019 Oct 07;27:104617
pubmed: 31656843
Circulation. 2010 Jun 1;121(21):2271-83
pubmed: 20479151
Am J Clin Nutr. 1999 Oct;70(4):439-47
pubmed: 10500011
Lancet Planet Health. 2018 Oct;2(10):e451-e461
pubmed: 30318102
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Sci Total Environ. 2018 Dec 10;644:77-94
pubmed: 29981520
Lancet Planet Health. 2017 Apr;1(1):e4-e5
pubmed: 29851591
Environ Health. 2014 Apr 07;13(1):27
pubmed: 24708803
Science. 2018 Jun 1;360(6392):987-992
pubmed: 29853680
Lancet. 2019 Feb 2;393(10170):447-492
pubmed: 30660336
PLoS One. 2019 Oct 17;14(10):e0223883
pubmed: 31622423
Eur J Epidemiol. 2018 Sep;33(9):847-858
pubmed: 29536223
Public Health Nutr. 2016 Oct;19(14):2654-61
pubmed: 26975578
Nutr Rev. 2017 Jan;75(1):2-17
pubmed: 27974596
Eur J Clin Nutr. 2019 Apr;73(4):624-633
pubmed: 30755710

Auteurs

Jessica E Laine (JE)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland; Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, London, UK. Electronic address: j.laine@imperial.ac.uk.

Inge Huybrechts (I)

International Agency for Research on Cancer, Lyon, France.

Marc J Gunter (MJ)

International Agency for Research on Cancer, Lyon, France.

Pietro Ferrari (P)

International Agency for Research on Cancer, Lyon, France.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, Lyon, France.

Kostas Tsilidis (K)

Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, London, UK.

Dagfinn Aune (D)

Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, London, UK; Department of Nutrition, Bjørknes University College, Oslo, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Ullevål, Oslo, Norway.

Matthias B Schulze (MB)

Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany.

Manuela Bergmann (M)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Elisabeth H M Temme (EHM)

Centre for Nutrition, Prevention and Health Services National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Jolanda M A Boer (JMA)

Centre for Nutrition, Prevention and Health Services National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Claudia Agnoli (C)

Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.

Ulrika Ericson (U)

Department of Clinical Sciences, Lund University, Malmö, Sweden.

Anna Stubbendorff (A)

Department of Clinical Sciences, Lund University, Malmö, Sweden.

Daniel B Ibsen (DB)

Research Unit for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.

Christina Catherine Dahm (CC)

Research Unit for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.

Mélanie Deschasaux (M)

Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center - University of Paris (CRESS), Bobigny, France.

Mathilde Touvier (M)

Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center - University of Paris (CRESS), Bobigny, France.

Emmanuelle Kesse-Guyot (E)

Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center - University of Paris (CRESS), Bobigny, France.

Maria-Jose Sánchez Pérez (MJ)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Miguel Rodríguez Barranco (M)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Keren Papier (K)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Anika Knuppel (A)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Marie-Christine Boutron-Ruault (MC)

CESP, Faculté de médecine, Université Paris-Saclay, UVSQ, INSERM, 94805, Villejuif, France.

Francesca Mancini (F)

CESP, Faculté de médecine, Université Paris-Saclay, UVSQ, INSERM, 94805, Villejuif, France.

Gianluca Severi (G)

CESP, Faculté de médecine, Université Paris-Saclay, UVSQ, INSERM, 94805, Villejuif, France; Gustave Roussy, F-94805, Villejuif, France; Department of Statistics, Computer Science and Applications "G. Parenti", University of Florence, Florence, Italy.

Bernard Srour (B)

Division of Cancer Epidemiology, German Cancer Rsearch Center Heidelberg, Heidelberg, Germany.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Rsearch Center Heidelberg, Heidelberg, Germany.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Guri Skeie (G)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Charlotta Rylander (C)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Torkjel M Sandanger (TM)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, London, UK.

Paolo Vineis (P)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, London, UK; Italian Institute of Technology, Genova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH